Hsa_circ_0061140 Knockdown Reverses FOXM1-Mediated Cell Growth and Metastasis in Ovarian Cancer Through MiR-370 Sponge Activity

Overview

Journal Mol Ther Nucleic Acids

Publisher Cell Press

Date 2018 Sep 22

PMID 30236833

Citations 67

Authors

Qizhen Chen

Jiarong Zhang

Yinyan He

Yanqiu Wang

Affiliations

Soon will be listed here.

Abstract

Circular RNAs (circRNAs) are a class of noncoding RNAs that regulate gene expression at the posttranscriptional level. The specific functions of circRNAs in ovarian cancer are yet to be established. Previous sequencing analyses have revealed an abnormal expression of hsa_circ_0061140 in ovarian cancer. The main aim of the present study is to establish the specific role of hsa_circ_0061140 in ovarian cancer. circRNA expression in ovarian cancer cells was detected via real-time qPCR. The effects on specific cellular characteristics (proliferation, migration, and the EMT) and subcellular localization of hsa_circ_0061140 were assessed via RNA fluorescence in situ hybridization, knockdown, and luciferase reporter assays in the SKOV3 and A2780 cell lines. Tumorigenesis was induced in nude mice to assess the effects of hsa_circ_0061140 on ovarian cancer growth in vivo. Our results showed that hsa_circ_0061140 was upregulated in ovarian cancer cell lines. Knockdown of hsa_circ_0061140 suppressed cell proliferation and migration, both in vivo and in vitro, by inhibiting FOXM1 expression through sponging miR-370. Overexpression of FOXM1 or suppression of miR-370 rescued hsa_circ_0061140 silencing-induced inhibition of cell proliferation, migration, and the EMT. The associations among hsa_circ_0061140, miR-370, and FOXM1 were confirmed via bioinformatic prediction and fluorescein reporter experiments. Thus, hsa_circ_0061140 appeared to function as a competing endogenous RNA of miR-370 that promoted cell growth and metastasis in ovarian cancer through regulation of the miR-370/FOXM1 pathway mediating EMT.

Citing Articles

Circ_0001068 accelerates the development of ovarian cancer by promoting FXYD5 expression through inhibiting mir-149-5p activity.

Mou Z, Ge L, Ye S, Gong Z Discov Oncol. 2024; 15(1):648.

PMID: 39532790 PMC: 11557794. DOI: 10.1007/s12672-024-01497-w.

Circ_0001741 exerts as a tumor promoter in ovarian cancer through the regulation of miR-491-5p/PRSS8 axis.

Wang D, Zhang S, Wang Q, Li P, Liu Y Discov Oncol. 2024; 15(1):643.

PMID: 39527152 PMC: 11554978. DOI: 10.1007/s12672-024-01474-3.

CircRNA as an Achilles heel of cancer: characterization, biomarker and therapeutic modalities.

Zhang J, Luo Z, Zheng Y, Duan M, Qiu Z, Huang C J Transl Med. 2024; 22(1):752.

PMID: 39127679 PMC: 11316389. DOI: 10.1186/s12967-024-05562-4.

Deregulated circRNAs in Epithelial Ovarian Cancer With Activity in Preclinical Models: Identification of Targets and New Modalities for Therapeutic Intervention.

Weidle U, Birzele F Cancer Genomics Proteomics. 2024; 21(3):213-237.

PMID: 38670587 PMC: 11059596. DOI: 10.21873/cgp.20442.

Role of circular RNA as competing endogenous RNA in ovarian cancer (Review).

Ye W, Xiang N, Wang Q, Lu Y Int J Mol Med. 2024; 53(5).

PMID: 38456562 PMC: 10998717. DOI: 10.3892/ijmm.2024.5365.

References

Liu H, Hu Y, Zhuang B, Yin J, Chen X, Wang J . Differential Expression of CircRNAs in Embryonic Heart Tissue Associated with Ventricular Septal Defect. Int J Med Sci. 2018; 15(7):703-712. PMC: 6001411. DOI: 10.7150/ijms.21660. View

Yuan Y, Haiying G, Zhuo L, Ying L, Xin H . Long non-coding RNA LINC00339 facilitates the tumorigenesis of non-small cell lung cancer by sponging miR-145 through targeting FOXM1. Biomed Pharmacother. 2018; 105:707-713. DOI: 10.1016/j.biopha.2018.06.022. View

Jia W, Xu B, Wu J . Circular RNA expression profiles of mouse ovaries during postnatal development and the function of circular RNA epidermal growth factor receptor in granulosa cells. Metabolism. 2018; 85:192-204. DOI: 10.1016/j.metabol.2018.04.002. View

Peake B, Eze S, Yang L, Castellino R, Nahta R . Growth differentiation factor 15 mediates epithelial mesenchymal transition and invasion of breast cancers through IGF-1R-FoxM1 signaling. Oncotarget. 2017; 8(55):94393-94406. PMC: 5706882. DOI: 10.18632/oncotarget.21765. View

Yang H, Wen L, Wen M, Liu T, Zhao L, Wu B . FoxM1 promotes epithelial-mesenchymal transition, invasion, and migration of tongue squamous cell carcinoma cells through a c-Met/AKT-dependent positive feedback loop. Anticancer Drugs. 2018; 29(3):216-226. PMC: 5821477. DOI: 10.1097/CAD.0000000000000585. View

Li J, Huang Y, Deng X, Luo M, Wang X, Hu H . Long noncoding RNA H19 promotes transforming growth factor-β-induced epithelial-mesenchymal transition by acting as a competing endogenous RNA of miR-370-3p in ovarian cancer cells. Onco Targets Ther. 2018; 11:427-440. PMC: 5783024. DOI: 10.2147/OTT.S149908. View

Pan X, Huang L, Wang X . MiR-370 functions as prognostic marker in patients with hepatocellular carcinoma. Eur Rev Med Pharmacol Sci. 2017; 21(16):3581-3585. View

Jiang M, Lash G, Zhao X, Long Y, Guo C, Yang H . CircRNA-0004904, CircRNA-0001855, and PAPP-A: Potential Novel Biomarkers for the Prediction of Preeclampsia. Cell Physiol Biochem. 2018; 46(6):2576-2586. DOI: 10.1159/000489685. View

Zhang N, Pati D . Separase Inhibitor Sepin-1 Inhibits Foxm1 Expression and Breast Cancer Cell Growth. J Cancer Sci Ther. 2018; 10(3). PMC: 5959057. DOI: 10.4172/1948-5956.1000517. View

10.

Zhang Y, Qiao W, Shan L . Expression and functional characterization of FOXM1 in non-small cell lung cancer. Onco Targets Ther. 2018; 11:3385-3393. PMC: 6001838. DOI: 10.2147/OTT.S162523. View

11.

Chen X, Chen Y, Lan J, Shen Z . MicroRNA-370 suppresses proliferation and promotes endometrioid ovarian cancer chemosensitivity to cDDP by negatively regulating ENG. Cancer Lett. 2014; 353(2):201-10. DOI: 10.1016/j.canlet.2014.07.026. View

12.

Wu J, Jiang Z, Chen C, Hu Q, Fu Z, Chen J . CircIRAK3 sponges miR-3607 to facilitate breast cancer metastasis. Cancer Lett. 2018; 430:179-192. DOI: 10.1016/j.canlet.2018.05.033. View

13.

Greenlee R, Murray T, Thun M . Cancer statistics, 2001. CA Cancer J Clin. 2001; 51(1):15-36. DOI: 10.3322/canjclin.51.1.15. View

14.

Xiao Z, Jia Y, Jiang W, Wang Z, Zhang Z, Gao Y . FOXM1: A potential indicator to predict lymphatic metastatic recurrence in stage IIA esophageal squamous cell carcinoma. Thorac Cancer. 2018; 9(8):997-1004. PMC: 6068428. DOI: 10.1111/1759-7714.12776. View

15.

Ouyang H, Chen X, Li W, Li Z, Nie Q, Zhang X . Circular RNA Promotes Myoblast Proliferation and Differentiation by Sponging miR-203 in Chicken. Front Genet. 2018; 9:172. PMC: 5964199. DOI: 10.3389/fgene.2018.00172. View

16.

Chen D, Zhang C, Lin J, Song X, Wang H . Screening differential circular RNA expression profiles reveal that hsa_circ_0128298 is a biomarker in the diagnosis and prognosis of hepatocellular carcinoma. Cancer Manag Res. 2018; 10:1275-1283. PMC: 5965387. DOI: 10.2147/CMAR.S166740. View

17.

Zhang Y, Ye X, Chen L, Wu Q, Gao Y, Li Y . PARI functions as a new transcriptional target of FOXM1 involved in gastric cancer development. Int J Biol Sci. 2018; 14(5):531-541. PMC: 5968845. DOI: 10.7150/ijbs.23945. View

18.

Natsuizaka M, Whelan K, Kagawa S, Tanaka K, Giroux V, Chandramouleeswaran P . Interplay between Notch1 and Notch3 promotes EMT and tumor initiation in squamous cell carcinoma. Nat Commun. 2017; 8(1):1758. PMC: 5700926. DOI: 10.1038/s41467-017-01500-9. View

19.

Shao F, Huang M, Meng F, Huang Q . Circular RNA Signature Predicts Gemcitabine Resistance of Pancreatic Ductal Adenocarcinoma. Front Pharmacol. 2018; 9:584. PMC: 5996282. DOI: 10.3389/fphar.2018.00584. View

20.

Nam E, Kim S, Lee T, Kim H, Lee J, Kim S . Primary and recurrent ovarian high-grade serous carcinomas display similar microRNA expression patterns relative to those of normal ovarian tissue. Oncotarget. 2016; 7(43):70524-70534. PMC: 5342571. DOI: 10.18632/oncotarget.12045. View